2型糖尿病肾衰竭及治疗获益的终生风险模型开发与验证:10年及终生风险预测模型
在瑞典国家糖尿病登记处707,077例2型糖尿病患者中开发Cox模型预测肾衰竭与全因死亡,并构建生命表计算无肾衰竭生存率;在苏格兰256,265例患者中外部验证,肾衰竭c统计量内部验证0.89、外部验证0.74,校准良好。
要点
- 模型可估算2型糖尿病患者10年及终生肾衰竭风险及预防治疗获得的无需肾衰竭生存年。
- 肾衰竭c统计量内部验证0.89(95%CI 0.88-0.90),外部验证0.74(95%CI 0.73-0.76)。
- 内部与外部验证的10年肾衰竭风险校准图显示观察值与预测值一致。
核心结论
- 研究推导并外部验证了一种预测工具,用于估算2型糖尿病个体10年及终生肾衰竭风险以及预防治疗获得的无需肾衰竭生存年,使用易获取的临床预测因子。
研究设计与样本
- 预测算法在瑞典国家糖尿病登记处2002-2019年707,077例 prevalent 和 incident 2型糖尿病患者中开发。
- 使用常规可获取预测因子分别构建肾衰竭(首次肾移植、长期透析或持续性eGFR<15 ml/min per 1.73 m2)和全因死亡的Cox比例回归函数,并合并入生命表计算以全因死亡为竞争结局的预测无肾衰竭生存率。
- 模型在苏格兰Care Information Diabetes数据库2004-2019年256,265例incident 2型糖尿病患者中外部验证。
主要发现
- 瑞典国家糖尿病登记处队列中位随访6.8年(四分位距3.2-10.6),8004例(1%)2型糖尿病个体发生肾衰竭,202,078例(29%)死亡。
- 肾衰竭c统计量内部验证为0.89(95%CI 0.88-0.90),外部验证为0.74(95%CI 0.73-0.76)。
- 内部与外部验证的校准图显示10年肾衰竭风险观察值与预测值一致性良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Individuals with type 2 diabetes are at a higher risk of developing kidney failure. The objective of this study was to develop and validate a decision support tool for estimating 10-year and lifetime risks of kidney failure in individuals with type 2 diabetes as well as estimating individual treatment effects of preventive medication. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The prediction algorithm was developed in 707,077 individuals with prevalent and incident type 2 diabetes from the Swedish National Diabetes Register for 2002-2019. Two Cox proportional regression functions for kidney failure (first occurrence of kidney transplantation, long-term dialysis, or persistent eGFR <15 ml/min per 1.73 m2) and all-cause mortality as respective end points were developed using routinely available predictors. These functions were combined into life tables to calculate the predicted survival without kidney failure while using all-cause mortality as the competing outcome. The model was externally validated in 256,265 individuals with incident type 2 diabetes from the Scottish Care Information Diabetes database between 2004 and 2019. RESULTS: During a median follow-up of 6.8 years (interquartile range, 3.2-10.6), 8004 (1%) individuals with type 2 diabetes in the Swedish National Diabetes Register cohort developed kidney failure, and 202,078 (29%) died. The model performed well, with c statistics for kidney failure of 0.89 (95% confidence interval, 0.88 to 0.90) for internal validation and 0.74 (95% confidence interval, 0.73 to 0.76) for external validation. Calibration plots showed good agreement in observed versus predicted 10-year risk of kidney failure for both internal and external validation. CONCLUSIONS: This study derived and externally validated a prediction tool for estimating 10-year and lifetime risks of kidney failure as well as life years free of kidney failure gained with preventive treatment in individuals with type 2 diabetes using easily available clinical predictors. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2022_11_04_CJN05020422.mp3.
引用
- Østergaard HB, Read SH, Sattar N, et al. Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction Models. Clin J Am Soc Nephrol. 2022. PMID: 36332974. doi:10.2215/CJN.05020422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。